Beyond cancer, SETDB1 appears to be involved in immune modulation observed in autoimmune diseases such as immune thrombocytopenia (ITP), where the transcriptional levels of human ERVs correlate with those of TRIM28/SETDB1 [56]. Here, SETDB1 is linked to cancer.